Diagnos Inc V.ADK

Alternate Symbol(s): DGNOF

Healthcare Medical Devices

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.

TSXV:ADK - Post by User

Diagnos Inc

Bullboard Posts

Comment by Caritas3on Dec 01, 2017 2:39pm

51 Views

Post# 27074218

RE:TEST NUMBERS

Not what they should be in my opinion. November 3rd at 191,000...and a month later 202,000. Only an increase of 11,000 tests. Based on the Mexican order alone...we should now be doing about 30,000/month.

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments